Tadmor T, Benjamini O, Goldschmidt N, Kreiniz N, Bairey O, Harel R, Sarid N, Levi T, Wolach O, Herishanu Y. Fixed-duration obinutuzumab-ibrutinib-venetoclax for Richter’s transformation: results from the phase II GIVeRS trial. Haematologica; https://doi.org/10.3324/haematol.2026.300749 [Early view].